TransMedics Group, Inc. (TMDX)
TMDX moved a median of +0.18% 30 minutes after news, and +0.64% by the close. How TMDX actually reacts to news — the realized, point-in-time move the market made, measured across 1,479 labeled events over the last three years with zero look-ahead.
TMDX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.08% | 56% | 1,478 |
| 30-min | +0.18% | 54% | 1,479 |
| 60-min | +0.09% | 52% | 1,479 |
| to close | +0.64% | 58% | 1,474 |
| Middle 50% of TMDX reactions | -0.73% to +1.23% |
|---|---|
| Median reaction (30-min) | +0.18% |
| Measured reactions | 1,479 |
Half of all TransMedics Group, Inc. news events land between -0.73% and +1.23% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How TMDX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 12 | +0.73% | 67% | +0.05% |
| Coverage initiations | 25 | +0.23% | 68% | +0.60% |
| Rating reiterations | 109 | +0.10% | 54% | -0.61% |
| Price-target raises | 29 | -0.03% | 41% | -0.83% |
| Price-target cuts | 20 | +0.01% | 50% | -0.96% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how TMDX ranks against every other measured name →
That’s how TMDX usually reacts — get an email when it moves on news →Email me when TMDX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TMDX's baseline. Nothing else.
Recent TMDX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -1.15% | -4.23% | |
| Form 8-K TransMedics Group, Inc. For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | +0.40% | -3.73% | |
| TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook | Press release | PR Newswire | +0.40% | -3.73% | |
| Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -0.46% | -0.98% | |
| TransMedics to Present at Upcoming September Investor Conferences | Press release | PR Newswire | +0.01% | -4.19% | |
| Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -1.18% | -0.02% | |
| Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | +0.43% | +1.26% | |
| Form 10-Q TransMedics Group, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.66% | +7.10% | |
| Form 8-K TransMedics Group, Inc. For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | +0.66% | +7.10% | |
| TransMedics Reports Second Quarter 2026 Financial Results | Press release | PR Newswire | +0.66% | +7.10% | |
| TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Press release | PR Newswire | -0.25% | +0.58% | |
| TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference | Press release | PR Newswire | +0.53% | +3.72% | |
| Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -0.27% | +2.38% | |
| TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 | Press release | PR Newswire | +0.93% | -4.17% | |
| TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH | Press release | PR Newswire | +0.94% | +1.98% | |
| Form SD TransMedics Group, Inc. | SEC filing · Form SD | SEC EDGAR | -1.51% | +1.69% | |
| Form 8-K TransMedics Group, Inc. For: May 20 | SEC filing · Form 8-K | SEC EDGAR | +0.58% | +0.64% | |
| TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Press release | PR Newswire | +0.58% | +0.64% | |
| TransMedics to Present at the William Blair 46th Annual Growth Stock Conference | Press release | PR Newswire | -1.15% | +2.83% | |
| Form DEFA14A TransMedics Group, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -1.76% | -6.48% | |
| Form 10-Q TransMedics Group, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.39% | -2.77% | |
| Form 8-K TransMedics Group, Inc. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -1.39% | -2.77% | |
| TransMedics Reports First Quarter 2026 Financial Results | Press release | PR Newswire | -1.39% | -2.77% | |
| TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH | Press release | PR Newswire | -1.65% | -2.07% | |
| TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting | Press release | PR Newswire | +2.01% | -1.92% | |
| TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026 | Press release | PR Newswire | +0.17% | +2.98% | |
| Form ARS TransMedics Group, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.16% | +3.67% | |
| Form DEF 14A TransMedics Group, Inc. For: May 20 | SEC filing · Form DEF | SEC EDGAR | +1.16% | +3.67% | |
| Form DEFA14A TransMedics Group, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +1.16% | +3.67% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +1.80% | +3.68% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.60% | -0.06% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.11% | +1.86% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.87% | -3.91% | |
| TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.22% | -3.26% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.01% | +0.47% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.38% | +0.04% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +0.17% | -2.08% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.10% | -1.13% | |
| TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.23% | +7.59% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +1.06% | +6.78% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.13% | +5.64% | |
| Form 8-K TransMedics Group, Inc. For: Feb 27 | SEC filing · Form 8-K | SEC EDGAR | -0.07% | +9.14% | |
| TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results | Press release | PR Newswire | -0.07% | +9.14% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.92% | +2.13% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.29% | +1.55% | |
| Form 10-K TransMedics Group, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -2.46% | -5.82% | |
| Form 8-K TransMedics Group, Inc. For: Feb 24 | SEC filing · Form 8-K | SEC EDGAR | -2.46% | -5.82% | |
| TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | PR Newswire | -2.46% | -5.82% | |
| TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | Press release | PR Newswire | -0.45% | +1.71% | |
| TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.00% | +1.42% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TMDX section they belong to.
Where else TMDX is measured.
TMDX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is TransMedics Group, Inc.'s median reaction calculated?
Every labeled TMDX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,479 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 54% of TMDX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TMDX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.